-
But the researchers stressed that all three vaccines, including the Pfizer and Johnson & Johnson shots, provide strong protection against people getting so sick that they end up in the hospital.
-
-
Moderna will ask the Food and Drug Administration to authorize its vaccine for kids ages 12 to 17 in early June, the company's CEO says.
-
In a new round of tests, the drug company wants to see if booster doses of its vaccine will ramp up defenses against emerging strains of the coronavirus.
-
Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.
-
A panel of experts advising the Food and Drug Administration weighs the safety and effectiveness of the COVID-19 vaccine from Moderna in a daylong public…
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.
-
The biotech company has new data reinforcing that its COVID-19 inoculation is safe and effective. Moderna is submitting an application to the FDA requesting emergency use authorization.
-
Investors were also reassured by comments from two Biden advisers that no nationwide COVID-19 lockdowns are being contemplated.